Another study showed that H19 regulated cell proliferation and metastasis by controlling miR-140-mediated iASPP expression in glioma, which could be a new therapeutic biomarker for glioma (Fig. 5C) 150. The gene discussed is PPP1R13L; the disease is central nervous system cancer.